TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||
Earning before tax | ---- | -54.29%28.17M | ---- | 25.62%61.62M | --32.7M | 1,293.86%49.05M | --3.52M |
Profit adjustment | |||||||
Interest (income) - adjustment | ---- | 6.26%-2.77M | ---- | -5,586.54%-2.96M | ---714K | ---52K | ---- |
Impairment and provisions: | ---- | 90.94%-30K | ---- | -202.16%-331K | --2K | 152.94%324K | ---612K |
-Other impairments and provisions | ---- | 90.94%-30K | ---- | -202.16%-331K | --2K | 152.94%324K | ---612K |
Revaluation surplus: | ---- | -135.66%-1.11M | ---- | 102.67%3.11M | --4.71M | 133.93%1.53M | ---4.52M |
-Other fair value changes | ---- | -135.66%-1.11M | ---- | 102.67%3.11M | --4.71M | 133.93%1.53M | ---4.52M |
Asset sale loss (gain): | ---- | -372.90%-506K | ---- | 25.17%-107K | ---106K | -476.32%-143K | --38K |
-Loss (gain) on sale of property, machinery and equipment | ---- | -372.90%-506K | ---- | 25.17%-107K | ---106K | -476.32%-143K | --38K |
Depreciation and amortization: | ---- | 5.75%24.51M | ---- | -5.36%23.18M | --10.96M | -1.93%24.49M | --24.97M |
-Depreciation | ---- | -2.62%21.6M | ---- | -7.90%22.18M | --10.57M | -2.07%24.08M | --24.59M |
-Amortization of intangible assets | ---- | --1.74M | ---- | ---- | ---- | ---- | ---- |
Financial expense | ---- | 15.24%4.12M | ---- | 2.49%3.58M | --1.58M | -4.44%3.49M | --3.65M |
Unrealized exchange loss (gain) | ---- | -191.69%-9.2M | ---- | 342.07%10.04M | ---11.61M | -65.82%2.27M | --6.64M |
Special items | ---- | --130K | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | -55.86%43.31M | ---- | 21.19%98.12M | --37.53M | 140.29%80.96M | --33.69M |
Change of operating capital | |||||||
Inventory (increase) decrease | ---- | 107.42%35K | ---- | -15.69%-472K | ---264K | -153.47%-408K | --763K |
Accounts receivable (increase)decrease | ---- | -161.99%-1.45M | ---- | -41.59%2.34M | ---4.15M | 253.34%4.01M | ---2.62M |
Accounts payable increase (decrease) | ---- | 237.75%25.07M | ---- | -58.42%7.42M | ---495K | 216.30%17.85M | ---15.35M |
Special items for working capital changes | ---- | ---- | ---- | ---- | --146K | 236.02%1.33M | ---980K |
Cash from business operations | ---- | -37.50%67.33M | ---- | 3.83%107.73M | --32.77M | 568.75%103.75M | --15.51M |
Other taxs | ---- | -34.80%-21.92M | ---- | -553.98%-16.26M | ---10.73M | -157.64%-2.49M | --4.31M |
Special items of business | -84.84%3.16M | ---- | --20.88M | ---- | ---- | ---- | ---- |
Net cash from operations | -84.84%3.16M | -50.35%45.42M | -5.26%20.88M | -9.67%91.47M | --22.04M | 410.74%101.26M | --19.83M |
Cash flow from investment activities | |||||||
Interest received - investment | 96.21%4.25M | -6.26%2.77M | 203.08%2.16M | 5,586.54%2.96M | --714K | --52K | ---- |
Loan receivable (increase) decrease | ---- | --12.91M | --12.91M | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---17.91M | ---197K | ---- | ---- | ---- | --1.96M | ---- |
Sale of fixed assets | 23,258.82%3.97M | -88.43%506K | -97.30%17K | 100.18%4.37M | --629K | --2.19M | ---- |
Purchase of fixed assets | 5.06%-14.7M | 6.91%-25.13M | -280.44%-15.48M | -560.93%-27M | ---4.07M | 69.89%-4.09M | ---13.57M |
Purchase of intangible assets | ---- | 78.68%-677K | 85.60%-266K | -265.06%-3.18M | ---1.85M | ---870K | ---- |
Acquisition of subsidiaries | ---- | ---14.55M | ---176K | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | -39.21%46.48M | -56.05%17.36M | 2,843.19%76.46M | --39.49M | -69.90%2.6M | --8.63M |
Cash on investment | ---- | 69.20%-41.61M | 38.20%-36.17M | -609.06%-135.09M | ---58.53M | -175.96%-19.05M | ---6.9M |
Net cash from investment operations | -24.17%-24.39M | 76.07%-19.49M | 16.81%-19.64M | -373.36%-81.47M | ---23.61M | -45.36%-17.21M | ---11.84M |
Net cash before financing | -1,820.10%-21.23M | 159.27%25.92M | 178.35%1.23M | -88.11%10M | ---1.58M | 952.37%84.05M | --7.99M |
Cash flow from financing activities | |||||||
Refund | 13.75%-3.24M | 28.50%-8.02M | -15.97%-3.75M | 24.19%-11.22M | ---3.24M | -29.02%-14.8M | ---11.47M |
Issuing shares | --17.14M | --222.86M | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | 5.12%-1.87M | -15.24%-4.12M | -24.70%-1.97M | -2.49%-3.58M | ---1.58M | 4.44%-3.49M | ---3.65M |
Dividends paid - financing | ---- | ---14.03M | ---- | ---- | ---- | ---- | ---- |
Absorb investment income | --680K | --9.41M | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | -347.33%-671K | ---6.31M | ---150K | ---- | ---- | ---- | ---- |
Other items of the financing business | -12.41%-1.08M | 7.93%-2.07M | -0.52%-959K | 13.21%-2.25M | ---954K | 4.99%-2.59M | ---2.72M |
Net cash from financing operations | 235.59%10.18M | 1,187.10%196.5M | -19.28%-7.51M | 16.98%-18.08M | ---6.3M | -16.45%-21.77M | ---18.7M |
Effect of rate | 199.91%2.26M | -803.47%-3.39M | 49.16%-2.26M | -141.35%-375K | ---4.44M | -81.38%907K | --4.87M |
Net Cash | -75.91%-11.04M | 2,853.48%222.43M | 20.26%-6.28M | -112.97%-8.08M | ---7.87M | 681.52%62.28M | ---10.71M |
Begining period cash | 254.45%305.12M | -8.94%86.08M | -8.94%86.08M | 201.56%94.54M | --94.54M | -15.70%31.35M | --37.19M |
Cash at the end | 282.13%296.34M | 254.45%305.12M | -5.69%77.55M | -8.94%86.08M | --82.22M | 201.56%94.54M | --31.35M |
Cash balance analysis | |||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.